Page 1 of Clinical Trials for Drug Doxorubicin Hydrochloride DOX, 1333 Total Matches
- 1RecruitingLast Updated: November 22, 2011Condition(s): Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage IV Adult Hodgkin Lymphoma
- 2Active, not recruitingLast Updated: June 23, 2005Condition(s): Sarcoma, Kaposi; HIV Infections
- 3CompletedLast Updated: April 13, 2012Condition(s): Sarcoma, Kaposi; HIV Infections
- 4CompletedLast Updated: May 12, 2012Condition(s): Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
- 5RecruitingLast Updated: May 11, 2012Condition(s): Breast Cancer; Metastatic Cancer
- 6CompletedLast Updated: September 14, 2011Condition(s): Male Breast Cancer; Nausea and Vomiting; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer
- 7CompletedLast Updated: June 23, 2005Condition(s): Sarcoma, Kaposi; HIV Infections
- 8RecruitingLast Updated: April 27, 2010Condition(s): Sarcoma
- 9CompletedLast Updated: December 28, 2011Condition(s): Breast Cancer; Drug/Agent Toxicity by Tissue/Organ; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- 10TerminatedLast Updated: January 24, 2012Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
- 11RecruitingLast Updated: September 20, 2011Condition(s): Fallopian Tube Cancer; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer
- 12RecruitingLast Updated: May 21, 2012Condition(s): Sarcoma; Chemotherapy-induced Nausea and Vomiting; Effects of Chemotherapy; Adverse Effects of Medical Drugs
- 13CompletedLast Updated: April 26, 2012Condition(s): Sarcoma, Kaposi; HIV Infections
- 14CompletedLast Updated: March 15, 2012Condition(s): Sarcoma, Kaposi; HIV Infections
- 15CompletedLast Updated: June 23, 2005Condition(s): Sarcoma, Kaposi; HIV Infections
- 16CompletedLast Updated: May 16, 2011Condition(s): Ovarian Neoplasms
- 17CompletedLast Updated: March 30, 2012Condition(s): Sarcoma, Kaposi; HIV Infections
- 18Active, not recruitingLast Updated: January 5, 2012Condition(s): Breast Cancer
- 19Active, not recruitingLast Updated: July 1, 2009Condition(s): Endometrial Cancer
- 20Active, not recruitingLast Updated: August 8, 2011Condition(s): HER2-negative Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Doxorubicin+Hydrochloride+DOX
